HomeOCD1 • FRA
add
Niagen Bioscience Inc
Previous close
€6.35
Day range
€6.60 - €6.70
Year range
€2.24 - €8.35
Market cap
592.46M USD
Avg Volume
44.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 29.12M | 37.41% |
Operating expense | 11.09M | -15.41% |
Net income | 7.18M | 6,197.37% |
Net profit margin | 24.65 | 4,464.81% |
Earnings per share | 0.03 | — |
EBITDA | 7.30M | 15,108.33% |
Effective tax rate | 4.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.51M | 63.79% |
Total assets | 68.28M | 24.22% |
Total liabilities | 22.18M | -16.31% |
Total equity | 46.09M | — |
Shares outstanding | 77.92M | — |
Price to book | 10.76 | — |
Return on assets | 28.49% | — |
Return on capital | 41.34% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 7.18M | 6,197.37% |
Cash from operations | 8.58M | 1,222.50% |
Cash from investing | -69.00K | -228.57% |
Cash from financing | 3.75M | 5,031.58% |
Net change in cash | 12.26M | 2,121.38% |
Free cash flow | 6.05M | 635.65% |
About
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
Founded
1999
Headquarters
Website
Employees
104
